Search

CPD and Education library

Study and gain CPD points through OT’s online CPD exams, and access archived CPD and CET articles, Practice team resources and Skills guides in our Education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Industry

News and features about the latest developments in optics with a focus on industry

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

UK researchers working to reduce treatments times for river blindness

A molecule that has the potential to more effectively target the cause of river blindness and elephantiasis will enter pre-clinical trials

Test tubes

UK researchers are developing a molecule that could improve treatment for river blindness – the second most common cause of blindness due to infection globally. 

Scientists from the University of Liverpool, Liverpool School of Tropical Medicine and Imperial College London describe the molecule in Proceedings of the National Academy of Sciences.

It has been designed to more effectively target the cause of river blindness and elephantiasis, while potentially having fewer side effects.

The treatment is expected to work faster than existing drugs, killing the parasitic worms that feature in river blindness in less than a week.

The molecule targets the wolbachia bacteria that lives within the worms.

Professor Ed Tate, from Imperial College London, said the mechanism used by researchers is “unique.”

“By identifying this new target, we will reveal new insights into the bacteria-worm symbiosis,” he said.

“These insights could in turn be exploited to develop still more effective drugs against the worms,” Professor Tate added.